Prof. Dr. Fabio Arturo Iannotti | life science | Best Researcher Award
PI,Institute of Biomolecular Chemistry ICB/ National Research Council CNR (Italy) , Italy
Fabio Arturo Iannotti is a renowned neuroscientist and pharmacologist born in Naples, Italy, in 1981. He holds a PhD in Neuroscience and currently serves as an Associate Professor at the Institute of Biomolecular Chemistry (ICB) – National Research Council (CNR). Iannotti’s research focuses on neuromuscular disorders, epilepsy, and the therapeutic potential of cannabinoids and natural products.
Profile
Education 🎓
Fabio Iannotti earned his Master’s degree in Medical Biotechnology from the University Federico II of Naples (2006). He then pursued his PhD in Neuroscience at the same university (2011). Iannotti also completed a research fellowship at the University of California, Davis (2009-2010) and served as a visiting researcher at the University of Reading (2012-2013).
Experience 💼
Fabio Iannotti has accumulated extensive research experience in academia and industry collaborations. He worked as a postdoctoral fellow at the University Federico II of Naples (2010-2011) and the Institute of Biomolecular Chemistry (ICB) – National Research Council (CNR) (2011-2014). Iannotti then held researcher positions at ICB-CNR (2014-2018, 2018-2023) before becoming an Associate Professor (2023-present).
Awards and Awards 🏆
Fabio Iannotti has received funding from various organizations, including the Italian National Recovery and Resilience Plan (PNRR), Duchenne Parent Project NL, and GW RESEARCH LTD. He has also filed international patents related to his research on cannabinoids and natural products.
Research Focus
Fabio Iannotti’s research focuses on understanding the molecular mechanisms underlying neuromuscular disorders, epilepsy, and the therapeutic potential of cannabinoids, natural products, and microbiota. He employs a multidisciplinary approach, combining molecular biology, pharmacology, and neuroscience to develop innovative treatments.
Publications 📚
1. Use of phytocannabinoids in degenerative muscle disorders 🌿
2. Microbial N-acyl amides: a novel class of probiotics in degenerative muscle disorders 🧬
3. Investigation into the effects of vitamin D on antipsychotic drug metabolic side effects: focus on the gut microbiome 🌞
4. Unravelling new pathways and innovative perspectives: a pilot study on gut microbiota-endocannabinoids interaction in Duchenne’s muscular dystrophy 🔬
5. Unravelling the pharmacological actions of phytocannabinoids on microbiota-host mitochondria crosstalk in Duchenne Muscular Dystrophy 🔬
6. Use of Cannabidiol (CBD), cannabidivarin (CBDV) and tetrahydrocannabivarin (THCV) as a novel therapeutic opportunity to reinforce muscle function in Duchenne’s Muscular Dystrophy (DMD) 🌿
7. Study of transient receptor potential cation channels subfamily V type 1 (TRPV1) and type 2 (TRPV2) as molecular targets of botanically derived phytocannabinoids for the treatment of intractable epilepsy 🧠
Conclusion
Dr. Fabio Arturo Iannotti’s outstanding research experience, groundbreaking research, leadership skills, and interdisciplinary expertise make him an ideal candidate for the Best Researcher Award. While there are areas for improvement, his strengths and achievements demonstrate exceptional dedication, expertise, and potential to drive transformative research.